BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ang CW, Jarrad AM, Cooper MA, Blaskovich MAT. Nitroimidazoles: Molecular Fireworks That Combat a Broad Spectrum of Infectious Diseases. J Med Chem 2017;60:7636-57. [PMID: 28463485 DOI: 10.1021/acs.jmedchem.7b00143] [Cited by in Crossref: 60] [Cited by in F6Publishing: 45] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Li Z, Gopala L, Tangadanchu VKR, Gao W, Zhou C. Discovery of novel nitroimidazole enols as Pseudomonas aeruginosa DNA cleavage agents. Bioorganic & Medicinal Chemistry 2017;25:6511-22. [DOI: 10.1016/j.bmc.2017.10.028] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
2 Butler MS, Paterson DL. Antibiotics in the clinical pipeline in October 2019. J Antibiot (Tokyo) 2020;73:329-64. [PMID: 32152527 DOI: 10.1038/s41429-020-0291-8] [Cited by in Crossref: 63] [Cited by in F6Publishing: 48] [Article Influence: 31.5] [Reference Citation Analysis]
3 Padia J, Kulakova L, Galkin A, Herzberg O. Discovery and Preclinical Development of Antigiardiasis Fumagillol Derivatives. Antimicrob Agents Chemother 2020;64:e00582-20. [PMID: 32778548 DOI: 10.1128/AAC.00582-20] [Reference Citation Analysis]
4 Tiwari P, Khare T, Shriram V, Bae H, Kumar V. Plant synthetic biology for producing potent phyto-antimicrobials to combat antimicrobial resistance. Biotechnol Adv 2021;48:107729. [PMID: 33705914 DOI: 10.1016/j.biotechadv.2021.107729] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
5 Ndayishimiye J, Popat A, Blaskovich M, Falconer JR. Formulation technologies and advances for oral delivery of novel nitroimidazoles and antimicrobial peptides. J Control Release 2020;324:728-49. [PMID: 32380201 DOI: 10.1016/j.jconrel.2020.05.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
6 Patterson S, Fairlamb AH. Current and Future Prospects of Nitro-compounds as Drugs for Trypanosomiasis and Leishmaniasis. Curr Med Chem 2019;26:4454-75. [PMID: 29701144 DOI: 10.2174/0929867325666180426164352] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
7 Showalter HD. Recent Progress in the Discovery and Development of 2-Nitroimidazooxazines and 6-Nitroimidazooxazoles to Treat Tuberculosis and Neglected Tropical Diseases. Molecules 2020;25:E4137. [PMID: 32927749 DOI: 10.3390/molecules25184137] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Patel OPS, Jesumoroti OJ, Legoabe LJ, Beteck RM. Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective. Eur J Med Chem 2021;210:112994. [PMID: 33234343 DOI: 10.1016/j.ejmech.2020.112994] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Velez ASMM, de Souza GA, Pitasse-santos P, de Alcântara Pinto DC, Decote-ricardo D, de Lima MEF. 2-Nitro-1-vinyl-1H-imidazole. Molbank 2022;2022:M1326. [DOI: 10.3390/m1326] [Reference Citation Analysis]
10 Soltani Rad M, Behrouz S, Mohammadtaghi-nezhad J, Zarenezhad E, Agholi M. Silica-tethered cuprous acetophenone thiosemicarbazone (STCATSC) as a novel hybrid nano-catalyst for highly efficient synthesis of new 1,2,3-triazolyl-based metronidazole hybrid analogues having potent antigiardial activity: STCATSC,1,2,3-triazolyl-based metronidazole antigiardial activity. Appl Organometal Chem 2019;33:e4799. [DOI: 10.1002/aoc.4799] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
11 Oliveira APA, Freitas JTJ, Diniz R, Pessoa C, Maranhão SS, Ribeiro JM, Souza-Fagundes EM, Beraldo H. Triethylphosphinegold(I) Complexes with Secnidazole-Derived Thiosemicarbazones: Cytotoxic Activity against HCT-116 Colorectal Cancer Cells under Hypoxia Conditions. ACS Omega 2020;5:2939-46. [PMID: 32095716 DOI: 10.1021/acsomega.9b03778] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Campos-fernández L, Barrientos-salcedo C, Herrera Valencia EE, Ortiz-muñiz R, Soriano-correa C. Substituent effects on the stability, physicochemical properties and chemical reactivity of nitroimidazole derivatives with potential antiparasitic effect: a computational study. New J Chem 2019;43:11125-34. [DOI: 10.1039/c9nj02207d] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Wang H, Wang Z, Wei C, Bai G, Chen Y, Wang J, Zhang L. Visible-light-promoted late-stage direct fluoroalkylation of nitroimidazoles. Tetrahedron Letters 2021;85:153484. [DOI: 10.1016/j.tetlet.2021.153484] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 do Vale Chaves e Mello F, Castro Salomão Quaresma BM, Resende Pitombeira MC, Araújo de Brito M, Farias PP, Lisboa de Castro S, Salomão K, Silva de Carvalho A, Oliveira de Paula JI, de Brito Nascimento S, Peixoto Cupello M, Paes MC, Boechat N, Felzenszwalb I. Novel nitroimidazole derivatives evaluated for their trypanocidal, cytotoxic, and genotoxic activities. European Journal of Medicinal Chemistry 2020;186:111887. [DOI: 10.1016/j.ejmech.2019.111887] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
15 Sharma A, Agrahari AK, Rajkhowa S, Tiwari VK. Emerging impact of triazoles as anti-tubercular agent. Eur J Med Chem 2022;238:114454. [PMID: 35597009 DOI: 10.1016/j.ejmech.2022.114454] [Reference Citation Analysis]
16 Pedron J, Boudot C, Brossas JY, Pinault E, Bourgeade-Delmas S, Sournia-Saquet A, Boutet-Robinet E, Destere A, Tronnet A, Bergé J, Bonduelle C, Deraeve C, Pratviel G, Stigliani JL, Paris L, Mazier D, Corvaisier S, Since M, Malzert-Fréon A, Wyllie S, Milne R, Fairlamb AH, Valentin A, Courtioux B, Verhaeghe P. New 8-Nitroquinolinone Derivative Displaying Submicromolar in Vitro Activities against Both Trypanosoma brucei and cruzi. ACS Med Chem Lett 2020;11:464-72. [PMID: 32292551 DOI: 10.1021/acsmedchemlett.9b00566] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Nepali K, Lee HY, Liou JP. Nitro-Group-Containing Drugs. J Med Chem 2019;62:2851-93. [PMID: 30295477 DOI: 10.1021/acs.jmedchem.8b00147] [Cited by in Crossref: 132] [Cited by in F6Publishing: 95] [Article Influence: 33.0] [Reference Citation Analysis]
18 Bresser PL, Vorster M, Sathekge MM. An overview of the developments and potential applications of 68Ga-labelled PET/CT hypoxia imaging. Ann Nucl Med 2021;35:148-58. [PMID: 33400147 DOI: 10.1007/s12149-020-01563-7] [Reference Citation Analysis]
19 Yang S, Zhang J, Yang R, Xu X. Small Molecule Compounds, A Novel Strategy against Streptococcus mutans. Pathogens 2021;10:1540. [PMID: 34959495 DOI: 10.3390/pathogens10121540] [Reference Citation Analysis]
20 Mignani S, Tripathi RP, Chen L, Caminade AM, Shi X, Majoral JP. New Ways to Treat Tuberculosis Using Dendrimers as Nanocarriers. Pharmaceutics 2018;10:E105. [PMID: 30049938 DOI: 10.3390/pharmaceutics10030105] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
21 Rossi R, Ciofalo M. An Updated Review on the Synthesis and Antibacterial Activity of Molecular Hybrids and Conjugates Bearing Imidazole Moiety. Molecules 2020;25:E5133. [PMID: 33158247 DOI: 10.3390/molecules25215133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Daher SS, Lee M, Jin X, Teijaro CN, Wheeler SE, Jacobson MA, Buttaro B, Andrade RB. Synthesis, Biological Evaluation, and Computational Analysis of Biaryl Side-Chain Analogs of Solithromycin. ChemMedChem 2021. [PMID: 34355515 DOI: 10.1002/cmdc.202100435] [Reference Citation Analysis]
23 Li Z, Tangadanchu VKR, Battini N, Bheemanaboina RRY, Zang Z, Zhang S, Zhou C. Indole-nitroimidazole conjugates as efficient manipulators to decrease the genes expression of methicillin-resistant Staphylococcus aureus. European Journal of Medicinal Chemistry 2019;179:723-35. [DOI: 10.1016/j.ejmech.2019.06.093] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
24 Mushtaque M, Avecilla F, Haque A, Yab Z, Rizvi MMA, Khan MS. Synthesis, structural and biological activity of N-substituted 2-methyl-4-/5-nitroimidazole derivatives. Journal of Molecular Structure 2019;1185:440-9. [DOI: 10.1016/j.molstruc.2019.02.101] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
25 Wang H, Wei C, Zou H, Linghu C, Wang Z, Wang J, Chen Y, Zhang L. Transition-metal-free, direct C-H radical trifluoromethylation of nitroimidazoles with Togni’s reagent. Tetrahedron Letters 2022. [DOI: 10.1016/j.tetlet.2022.153659] [Reference Citation Analysis]
26 Yang S, Lyu X, Zhang J, Shui Y, Yang R, Xu X. The Application of Small Molecules to the Control of Typical Species Associated With Oral Infectious Diseases. Front Cell Infect Microbiol 2022;12:816386. [DOI: 10.3389/fcimb.2022.816386] [Reference Citation Analysis]
27 Rawat A, Singh P, Jyoti A, Kaushik S, Srivastava VK. Averting transmission: A pivotal target to manage amoebiasis. Chem Biol Drug Des 2020;96:731-44. [PMID: 32356312 DOI: 10.1111/cbdd.13699] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
28 Singh R, Shaheer M, Sobhia ME. Molecular dynamic assisted investigation on impact of mutations in deazaflavin dependent nitroreductase against pretomanid: a computational study. J Biomol Struct Dyn 2022;:1-23. [PMID: 35574601 DOI: 10.1080/07391102.2022.2069156] [Reference Citation Analysis]
29 Giacomazzo GE, Conti L, Guerri A, Pagliai M, Fagorzi C, Sfragano PS, Palchetti I, Pietraperzia G, Mengoni A, Valtancoli B, Giorgi C. Nitroimidazole-Based Ruthenium(II) Complexes: Playing with Structural Parameters to Design Photostable and Light-Responsive Antibacterial Agents. Inorg Chem 2021. [PMID: 34793162 DOI: 10.1021/acs.inorgchem.1c03032] [Reference Citation Analysis]
30 Riches A, Hart CJS, Trenholme KR, Skinner-Adams TS. Anti-Giardia Drug Discovery: Current Status and Gut Feelings. J Med Chem 2020;63:13330-54. [PMID: 32869995 DOI: 10.1021/acs.jmedchem.0c00910] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
31 Garzón V, Bustos RH, G Pinacho D. Personalized Medicine for Antibiotics: The Role of Nanobiosensors in Therapeutic Drug Monitoring. J Pers Med 2020;10:E147. [PMID: 32993004 DOI: 10.3390/jpm10040147] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
32 Elvir-Lazo OL, White PF, Cruz Eng H, Yumul F, Chua R, Yumul R. Impact of chronic medications in the perioperative period: mechanisms of action and adverse drug effects (Part I). Postgrad Med 2021;:1-14. [PMID: 34551662 DOI: 10.1080/00325481.2021.1982297] [Reference Citation Analysis]
33 Teng Q, Sun G, Luo S, Wang K, Liang F. Design, syntheses and antitumor activities evaluation of 1,5‐diaryl substituted pyrazole secnidazole ester derivatives. J Heterocyclic Chem 2021;58:1656-64. [DOI: 10.1002/jhet.4302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Jiang S, Zeng J, Zhou X, Li Y. Drug Resistance and Gene Transfer Mechanisms in Respiratory/Oral Bacteria. J Dent Res 2018;97:1092-9. [PMID: 29928825 DOI: 10.1177/0022034518782659] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
35 Mali HM, Sabale SS, Degani MS, Borkute R, Choudhari AS, Sarkar D, Krishna VS, Sriram D. Rational design of coumarin derivatives as antituberculosis agents. Future Medicinal Chemistry 2018;10:2431-44. [DOI: 10.4155/fmc-2018-0015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Mathias F, Crozet MD, Kabri Y, Vanelle P. Rapid synthesis of new 2-methyl-7-nitro-5-substituted-2,3-dihydroimidazo[5,1- b ]oxazole as potential antibacterial drugs through one-pot cyclization and Suzuki–Miyaura coupling. Synthetic Communications 2018;48:1213-9. [DOI: 10.1080/00397911.2018.1439177] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
37 Zhang J, Ba Y, Wang S, Yang H, Hou X, Xu Z. Nitroimidazole-containing compounds and their antibacterial and antitubercular activities. Eur J Med Chem 2019;179:376-88. [PMID: 31260891 DOI: 10.1016/j.ejmech.2019.06.068] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
38 Satta M, Casavola AR, Cartoni A, Castrovilli MC, Catone D, Chiarinelli J, Borocci S, Avaldi L, Bolognesi P. Ionization of 2- and 4(5)-Nitroimidazoles Radiosensitizers: A "Kinetic Competition" Between NO2 and NO Losses. Chemphyschem 2021;22:2387-91. [PMID: 34597457 DOI: 10.1002/cphc.202100629] [Reference Citation Analysis]
39 Ma Z, He S, Yuan Y, Zhuang Z, Liu Y, Wang H, Chen J, Xu X, Ding C, Molodtsov V, Lin W, Robertson GT, Weiss WJ, Pulse M, Nguyen P, Duncan L, Doyle T, Ebright RH, Lynch AS. Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial Pathogens. J Med Chem 2022. [PMID: 35175750 DOI: 10.1021/acs.jmedchem.1c02045] [Reference Citation Analysis]
40 Thomas C, Gwenin CD. The Role of Nitroreductases in Resistance to Nitroimidazoles. Biology (Basel) 2021;10:388. [PMID: 34062712 DOI: 10.3390/biology10050388] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
41 Bai Y, Mao J, Li D, Luo X, Chen J, Tay FR, Niu L. Bimodal antibacterial system based on quaternary ammonium silane-coupled core-shell hollow mesoporous silica. Acta Biomaterialia 2019;85:229-40. [DOI: 10.1016/j.actbio.2018.12.037] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
42 Zhang G, Maddili SK, Tangadanchu VKR, Gopala L, Gao W, Cai G, Zhou C. Discovery of natural berberine-derived nitroimidazoles as potentially multi-targeting agents against drug-resistant Escherichia coli. Sci China Chem 2018;61:557-68. [DOI: 10.1007/s11426-017-9169-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 6.6] [Reference Citation Analysis]
43 Rice AM, Long Y, King SB. Nitroaromatic Antibiotics as Nitrogen Oxide Sources. Biomolecules 2021;11:267. [PMID: 33673069 DOI: 10.3390/biom11020267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
44 Salillas S, Sancho J. Flavodoxins as Novel Therapeutic Targets against Helicobacter pylori and Other Gastric Pathogens. Int J Mol Sci 2020;21:E1881. [PMID: 32164177 DOI: 10.3390/ijms21051881] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
45 Jarrad AM, Ang CW, Debnath A, Hahn HJ, Woods K, Tan L, Sykes ML, Jones AJ, Pelingon R, Butler MS, Avery VM, West NP, Karoli T, Blaskovich MAT, Cooper MA. Design, Synthesis, and Biological Evaluation of 2-Nitroimidazopyrazin-one/-es with Antitubercular and Antiparasitic Activity. J Med Chem 2018;61:11349-71. [PMID: 30468386 DOI: 10.1021/acs.jmedchem.8b01578] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
46 Wijnant GJ, Croft SL, de la Flor R, Alavijeh M, Yardley V, Braillard S, Mowbray C, Van Bocxlaer K. Pharmacokinetics and Pharmacodynamics of the Nitroimidazole DNDI-0690 in Mouse Models of Cutaneous Leishmaniasis. Antimicrob Agents Chemother 2019;63:e00829-19. [PMID: 31262757 DOI: 10.1128/AAC.00829-19] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
47 Tao X, Gao C, Huang ZG, Luo W, Liu KL, Peng CT, Ding CZ, Li J, Chen SH, Yu LT. Discovery and evaluation of novel nitrodihydroimidazooxazoles as promising anti-tuberculosis agents. Bioorg Med Chem Lett 2019;29:2511-5. [PMID: 31353295 DOI: 10.1016/j.bmcl.2019.06.055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Zhang C, Kuang X, Zhou Y, Peng X, Guo Q, Yang T, Zhou X, Luo Y, Xu X. A Novel Small Molecule, ZY354, Inhibits Dental Caries-Associated Oral Biofilms. Antimicrob Agents Chemother 2019;63:e02414-18. [PMID: 30858201 DOI: 10.1128/AAC.02414-18] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
49 Rice AM, Faig A, Wolff DE, King SB. Sodium borohydride and thiol mediated nitrite release from nitroaromatic antibiotics. Bioorg Med Chem Lett 2021;48:128245. [PMID: 34242759 DOI: 10.1016/j.bmcl.2021.128245] [Reference Citation Analysis]
50 Zhou Y, Ju Y, Yang Y, Sang Z, Wang Z, He G, Yang T, Luo Y. Discovery of hybrids of indolin-2-one and nitroimidazole as potent inhibitors against drug-resistant bacteria. J Antibiot 2018;71:887-97. [DOI: 10.1038/s41429-018-0076-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
51 Ang CW, Tan L, Sykes ML, AbuGharbiyeh N, Debnath A, Reid JC, West NP, Avery VM, Cooper MA, Blaskovich MAT. Antitubercular and Antiparasitic 2-Nitroimidazopyrazinones with Improved Potency and Solubility. J Med Chem 2020;63:15726-51. [PMID: 33151678 DOI: 10.1021/acs.jmedchem.0c01372] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
52 Oliveira AA, Oliveira APA, Franco LL, Ferencs MO, Ferreira JFG, Bachi SMPS, Speziali NL, Farias LM, Magalhães PP, Beraldo H. 5-Nitroimidazole-derived Schiff bases and their copper(II) complexes exhibit potent antimicrobial activity against pathogenic anaerobic bacteria. Biometals 2018;31:571-84. [DOI: 10.1007/s10534-018-0106-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
53 Bresser PL, Sathekge MM, Vorster M. PET/CT features of a novel gallium-68 labelled hypoxia seeking agent in patients diagnosed with tuberculosis: a proof-of-concept study. Nucl Med Commun 2022. [PMID: 35506285 DOI: 10.1097/MNM.0000000000001580] [Reference Citation Analysis]
54 Abid WK, Naser AI. The efficacy of a new paste formulation as an alternative therapeutic agent for traumatic ulcers. J Taibah Univ Med Sci 2021;16:724-32. [PMID: 34690654 DOI: 10.1016/j.jtumed.2021.05.005] [Reference Citation Analysis]
55 Pedron J, Boudot C, Hutter S, Bourgeade-Delmas S, Stigliani JL, Sournia-Saquet A, Moreau A, Boutet-Robinet E, Paloque L, Mothes E, Laget M, Vendier L, Pratviel G, Wyllie S, Fairlamb A, Azas N, Courtioux B, Valentin A, Verhaeghe P. Novel 8-nitroquinolin-2(1H)-ones as NTR-bioactivated antikinetoplastid molecules: Synthesis, electrochemical and SAR study. Eur J Med Chem 2018;155:135-52. [PMID: 29885575 DOI: 10.1016/j.ejmech.2018.06.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
56 Salillas S, Alías M, Michel V, Mahía A, Lucía A, Rodrigues L, Bueno J, Galano-frutos JJ, De Reuse H, Velázquez-campoy A, Carrodeguas JA, Sostres C, Castillo J, Aínsa JA, Díaz-de-villegas MD, Lanas Á, Touati E, Sancho J. Design, Synthesis, and Efficacy Testing of Nitroethylene- and 7-Nitrobenzoxadiazol-Based Flavodoxin Inhibitors against Helicobacter pylori Drug-Resistant Clinical Strains and in Helicobacter pylori -Infected Mice. J Med Chem 2019;62:6102-15. [DOI: 10.1021/acs.jmedchem.9b00355] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
57 AbdelKhalek A, Mohammad H, Mayhoub AS, Seleem MN. Screening for potent and selective anticlostridial leads among FDA-approved drugs. J Antibiot (Tokyo) 2020;73:392-409. [PMID: 32132676 DOI: 10.1038/s41429-020-0288-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
58 Hedges JB, Ryan KS. In vitro Reconstitution of the Biosynthetic Pathway to the Nitroimidazole Antibiotic Azomycin. Angew Chem Int Ed 2019;58:11647-51. [DOI: 10.1002/anie.201903500] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
59 Gowri M, Suganya K, Latha N, Murugan M, Ahmed M, Alarfaj AA, Rajan M. Metal oxide nanoparticle-functionalized sebacic acid-grafted PHEAM nanocarriers for enriched activity of metronidazole against food borne bacteria: in vitro and in vivo study. New J Chem 2018;42:18437-47. [DOI: 10.1039/c8nj03718c] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
60 Nóbile ML, Stricker AM, Marchesano L, Iribarren AM, Lewkowicz ES. N-oxygenation of amino compounds: Early stages in its application to the biocatalyzed preparation of bioactive compounds. Biotechnol Adv 2021;:107726. [PMID: 33675955 DOI: 10.1016/j.biotechadv.2021.107726] [Reference Citation Analysis]
61 Mignani S, Bignon J, Shi X, Majoral JP. First-in-Class Phosphorus Dendritic Framework, a Wide Surface Functional Group Palette Bringing Noteworthy Anti-Cancer and Anti-Tuberculosis Activities: What Lessons to Learn? Molecules 2021;26:3708. [PMID: 34204564 DOI: 10.3390/molecules26123708] [Reference Citation Analysis]